PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
33955122-10	2021	RESULTS: Our results revealed that miR-373-3p acted as an EMT inhibitor in JEG-3 and JAR cells; this was due to its mediation of the transforming growth factor-beta (TGFbeta) signaling pathway, which was responsible for EMT.	mir-373-3p	35-45	tumor necrosis factor	Homo sapiens	133-164
33955122-10	2021	RESULTS: Our results revealed that miR-373-3p acted as an EMT inhibitor in JEG-3 and JAR cells; this was due to its mediation of the transforming growth factor-beta (TGFbeta) signaling pathway, which was responsible for EMT.	mir-373-3p	35-45	transforming growth factor alpha	Homo sapiens	166-173
33106913-13	2021	Silencing miR-373-3p reversed the promoting effect of MSC-AS1 or CPEB4 knockdown on TMZ sensitivity.	mir-373-3p	10-20	prostaglandin D2 receptor	Homo sapiens	58-61
33106913-13	2021	Silencing miR-373-3p reversed the promoting effect of MSC-AS1 or CPEB4 knockdown on TMZ sensitivity.	mir-373-3p	10-20	cytoplasmic polyadenylation element binding protein 4	Homo sapiens	65-70
30021382-0	2018	MiR-373-3p enhances the chemosensitivity of gemcitabine through cell cycle pathway by targeting CCND2 in pancreatic carcinoma cells.	mir-373-3p	0-10	cyclin D2	Homo sapiens	96-101
34643247-12	2021	Notably, transfection with miR-373-3p inhibitor rescued sh-TGF-beta-R2-suppressed cell proliferation and migration.	mir-373-3p	27-37	transforming growth factor alpha	Homo sapiens	59-67
34200891-0	2021	miR-373-3p Regulates Invasion and Migration Abilities of Trophoblast Cells via Targeted CD44 and Radixin.	mir-373-3p	0-10	CD44 molecule (Indian blood group)	Homo sapiens	88-92
34200891-0	2021	miR-373-3p Regulates Invasion and Migration Abilities of Trophoblast Cells via Targeted CD44 and Radixin.	mir-373-3p	0-10	radixin	Homo sapiens	97-104
35574392-10	2022	In addition, miR-373-3p was screened out and identified to inhibit OVCAR3 invasion via negative regulation of TBC1D2.	mir-373-3p	13-23	carbonic anhydrase 3	Mus musculus	67-73
35574392-10	2022	In addition, miR-373-3p was screened out and identified to inhibit OVCAR3 invasion via negative regulation of TBC1D2.	mir-373-3p	13-23	TBC1 domain family, member 2	Mus musculus	110-116
34983307-11	2022	Furthermore, miR-373-3p overexpression elevated Bax and caspase 3 expressions and attenuated Bcl2"s level.	mir-373-3p	13-23	caspase 3	Mus musculus	56-65
34983307-11	2022	Furthermore, miR-373-3p overexpression elevated Bax and caspase 3 expressions and attenuated Bcl2"s level.	mir-373-3p	13-23	B cell leukemia/lymphoma 2	Mus musculus	93-97
34983307-13	2022	miR-373-3p cramped PI3K/AKT pathway activation.	mir-373-3p	0-10	thymoma viral proto-oncogene 1	Mus musculus	24-27
34983307-14	2022	miR-373-3p negatively modulated TFAP4, and TFAP4 overexpression inverted miR-373-3p-mediated anti-tumor effects.	mir-373-3p	0-10	transcription factor AP4	Mus musculus	32-37
34983307-14	2022	miR-373-3p negatively modulated TFAP4, and TFAP4 overexpression inverted miR-373-3p-mediated anti-tumor effects.	mir-373-3p	73-83	transcription factor AP4	Mus musculus	43-48
34983307-16	2022	Collectively, miR-373-3p functions as an anti-tumor gene in HCC by inhibiting TFAP4/PI3K/AKT pathway.	mir-373-3p	14-24	transcription factor AP4	Mus musculus	78-83
34983307-16	2022	Collectively, miR-373-3p functions as an anti-tumor gene in HCC by inhibiting TFAP4/PI3K/AKT pathway.	mir-373-3p	14-24	thymoma viral proto-oncogene 1	Mus musculus	89-92
34236826-8	2021	Mechanistically, we found that AKT1 gene can be targeted by miR-373-3p.	mir-373-3p	60-70	thymoma viral proto-oncogene 1	Mus musculus	31-35
34236826-9	2021	MiR-373-3p mimic decreased the mRNA and protein expression of AKT1, while the miR-373-3p inhibitor increased the level of AKT1 in cervical cancer cells.	mir-373-3p	0-10	thymoma viral proto-oncogene 1	Mus musculus	62-66
34236826-9	2021	MiR-373-3p mimic decreased the mRNA and protein expression of AKT1, while the miR-373-3p inhibitor increased the level of AKT1 in cervical cancer cells.	mir-373-3p	78-88	thymoma viral proto-oncogene 1	Mus musculus	122-126
34236826-10	2021	AKT1 overexpression rescued the proliferation of cervical cancer cells transfected with miR-373-3p.	mir-373-3p	88-98	thymoma viral proto-oncogene 1	Mus musculus	0-4
34236826-11	2021	CONCLUSION: MiR-373-3p can serve as a novel anti-tumor microRNA in cervical cancer by targeting AKT1.	mir-373-3p	12-22	thymoma viral proto-oncogene 1	Mus musculus	96-100
34983307-11	2022	Furthermore, miR-373-3p overexpression elevated Bax and caspase 3 expressions and attenuated Bcl2"s level.	mir-373-3p	13-23	BCL2-associated X protein	Mus musculus	48-51